Dr. Armstrong is committed to health outcomes research. She is interested in examining ways by which new therapies and healthcare models improve patients’ disease states, quality of life, and their access to medical care. She conducts rigorous clinical studies that test new, technology-enabled models of healthcare delivery aimed at increasing patient access to specialty care. Dr. Armstrong has led multiple investigator-initiated studies that use health information technology to improve outcomes in dermatology patients. She examined whether interactive teledermatology was an economically viable means of providing dermatological care to medically underserved patients in remote areas. Dr. Armstrong was among the first investigators that examined strategies to improve patient adherence to therapy in dermatology.

Dr. Armstrong’s clinical interest in dermatology lies in psoriasis and atopic dermatitis. She conducts clinical studies in patients with these two skin conditions with an emphasis on investigating effective and safe uses of systemic therapies. She is especially interested in studying the mechanisms linking psoriasis and cardiovascular disease and how systemic treatments for psoriasis may affect various co-morbid conditions.